Sarepta Therapeutics (SRPT) Shares Repurchased (2018 - 2025)
Sarepta Therapeutics (SRPT) has 10 years of Shares Repurchased data on record, last reported at -$63.2 million in Q3 2025.
- For Q3 2025, Shares Repurchased fell 228.91% year-over-year to -$63.2 million; the TTM value through Dec 2025 reached $25.0 million, changed N/A, while the annual FY2025 figure was $25.0 million, N/A changed from the prior year.
- Shares Repurchased reached -$63.2 million in Q3 2025 per SRPT's latest filing, down from $41.6 million in the prior quarter.
- Across five years, Shares Repurchased topped out at $102.9 million in Q2 2022 and bottomed at -$149.9 million in Q4 2024.
- Average Shares Repurchased over 5 years is $29.2 million, with a median of $45.2 million recorded in 2024.
- Peak YoY movement for Shares Repurchased: surged 255.18% in 2022, then crashed 427.01% in 2024.
- A 5-year view of Shares Repurchased shows it stood at $29.8 million in 2021, then soared by 69.6% to $50.5 million in 2022, then dropped by 9.27% to $45.8 million in 2023, then plummeted by 427.01% to -$149.9 million in 2024, then surged by 57.85% to -$63.2 million in 2025.
- Per Business Quant database, its latest 3 readings for Shares Repurchased were -$63.2 million in Q3 2025, $41.6 million in Q2 2025, and $46.6 million in Q1 2025.